Norris Perne & French LLP MI Purchases 146,549 Shares of Danaher Corporation $DHR

Norris Perne & French LLP MI boosted its position in shares of Danaher Corporation (NYSE:DHR) by 122.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 265,854 shares of the conglomerate’s stock after buying an additional 146,549 shares during the period. Danaher comprises 2.6% of Norris Perne & French LLP MI’s portfolio, making the stock its 6th biggest holding. Norris Perne & French LLP MI’s holdings in Danaher were worth $58,900,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Gunderson Capital Management LLC acquired a new stake in Danaher in the 3rd quarter valued at about $765,000. EP Wealth Advisors LLC acquired a new position in shares of Danaher during the 2nd quarter worth approximately $3,807,000. Frank Rimerman Advisors LLC grew its position in shares of Danaher by 181.9% in the third quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate’s stock valued at $9,051,000 after purchasing an additional 26,363 shares in the last quarter. Birch Hill Investment Advisors LLC grew its position in shares of Danaher by 9.6% in the third quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate’s stock valued at $8,984,000 after purchasing an additional 3,553 shares in the last quarter. Finally, Forbes J M & Co. LLP increased its holdings in shares of Danaher by 141.6% in the third quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate’s stock valued at $947,000 after purchasing an additional 2,506 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Wall Street Analyst Weigh In

DHR has been the subject of several recent research reports. Barclays increased their price target on Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday. Robert W. Baird boosted their price objective on Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research note on Thursday. UBS Group restated a “buy” rating and issued a $260.00 target price on shares of Danaher in a report on Thursday. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $275.00 target price on shares of Danaher in a research note on Thursday. Finally, Stifel Nicolaus lifted their price target on Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Stock Performance

Danaher stock opened at $230.36 on Friday. The firm has a 50 day simple moving average of $216.32 and a 200-day simple moving average of $197.35. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.25. The stock has a market cap of $162.07 billion, a price-to-earnings ratio of 37.70, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.89 EPS. On average, analysts expect that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 26.19%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.